# Study With Aminophylline to Attenuate of the Side Effects of Regadenoson

> **NCT01250496** · PHASE4 · TERMINATED · sponsor: **Rush University Medical Center** · enrollment: 248 (actual)

## Conditions studied

- Patients Being Assessed With Nuclear Stress Testing of the Heart Using the Stress Agent Regadenoson, Lexiscan

## Interventions

- **DRUG:** Aminophylline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01250496
- **Lead sponsor:** Rush University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-11
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 248 (ACTUAL)
- **Why stopped:** Due to nationwide shortage of Aminophylline. Enrolled subjects did not complete study.
- **Last updated:** 2023-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01250496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01250496, "Study With Aminophylline to Attenuate of the Side Effects of Regadenoson". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01250496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*